| Mckayla Figueroa, PT, DPT, ATC | |
|
8901 W Lincoln Ave, West Allis, WI 53227-2409 | |
| (414) 328-6641 | |
| Not Available |
| Full Name | Mckayla Figueroa |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 8901 W Lincoln Ave, West Allis, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093353583 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Provider Name | Aurora Advanced Healthcare Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1265629133 PECOS PAC ID: 3375625833 Enrollment ID: O20080123000694 |
News Archive
Alexza Pharmaceuticals, Inc. announced today that it has established a collaboration with Biovail Laboratories International SRL, a subsidiary of Biovail Corporation, to develop and commercialize AZ-004 (Staccato® loxapine) in the U.S. and Canada. AZ-004 is Alexza's lead program, based on the company's proprietary technology, the Staccato system. Alexza submitted its New Drug Application (NDA) for Staccato loxapine in December 2009. Alexza is seeking regulatory approval to market AZ-004, an inhalation product candidate developed for the rapid treatment of agitation in patients with schizophrenia or bipolar disorder.
Nordic Naturals has earned certification from NSF International, verifying that its new LEED-designed corporate headquarters complies with Good Manufacturing Practices as set forth in NSF/ANSI Standard 173-2008, Dietary Supplements, Section 8.
Chronic inflammation has been directly associated with heart disease and other physical ailments. But LSU graduate student Nathanial Gilbert and Professor of Biological Sciences Marcia Newcomer, together with Associate Professor Sue Bartlett, have developed the first 3-D model of Human 5-Lipoxygenase, or 5-LOX, the molecule responsible for creating inflammatory compounds that provoke asthma.
Research led by Chu Chen, PhD, Associate Professor of Neuroscience at LSU Health Sciences Center New Orleans, has identified an enzyme called Monoacylglycerol lipase (MAGL) as a new therapeutic target to treat or prevent Alzheimer's disease.
The University of Arizona Medical Center for the first time will be part of a national effort to detect life-threatening non-cardiac vascular diseases. UMC is partnering with the American Vascular Association to offer free screenings for people at high risk: 60 years or older with a history of hypertension, diabetes, smoking, high cholesterol, or known cardiovascular disease.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mckayla Figueroa, PT, DPT, ATC 1404 Hawthorn Dr, Waukesha, WI 53188-2366 Ph: (262) 391-2465 | Mckayla Figueroa, PT, DPT, ATC 8901 W Lincoln Ave, West Allis, WI 53227-2409 Ph: (414) 328-6641 |
News Archive
Alexza Pharmaceuticals, Inc. announced today that it has established a collaboration with Biovail Laboratories International SRL, a subsidiary of Biovail Corporation, to develop and commercialize AZ-004 (Staccato® loxapine) in the U.S. and Canada. AZ-004 is Alexza's lead program, based on the company's proprietary technology, the Staccato system. Alexza submitted its New Drug Application (NDA) for Staccato loxapine in December 2009. Alexza is seeking regulatory approval to market AZ-004, an inhalation product candidate developed for the rapid treatment of agitation in patients with schizophrenia or bipolar disorder.
Nordic Naturals has earned certification from NSF International, verifying that its new LEED-designed corporate headquarters complies with Good Manufacturing Practices as set forth in NSF/ANSI Standard 173-2008, Dietary Supplements, Section 8.
Chronic inflammation has been directly associated with heart disease and other physical ailments. But LSU graduate student Nathanial Gilbert and Professor of Biological Sciences Marcia Newcomer, together with Associate Professor Sue Bartlett, have developed the first 3-D model of Human 5-Lipoxygenase, or 5-LOX, the molecule responsible for creating inflammatory compounds that provoke asthma.
Research led by Chu Chen, PhD, Associate Professor of Neuroscience at LSU Health Sciences Center New Orleans, has identified an enzyme called Monoacylglycerol lipase (MAGL) as a new therapeutic target to treat or prevent Alzheimer's disease.
The University of Arizona Medical Center for the first time will be part of a national effort to detect life-threatening non-cardiac vascular diseases. UMC is partnering with the American Vascular Association to offer free screenings for people at high risk: 60 years or older with a history of hypertension, diabetes, smoking, high cholesterol, or known cardiovascular disease.
› Verified 7 days ago
Stacy Barry Coffey, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6737 W Washington St, Suite 2250, West Allis, WI 53214 Phone: 414-266-4095 Fax: 414-431-6064 | |
Easter Seals Southeast Wisconsin Inc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2222 S 114th St, West Allis, WI 53227 Phone: 414-449-4444 Fax: 414-571-5568 | |
Mrs. Mary Paula Mueller, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 8802 W Becher St, West Allis, WI 53227 Phone: 414-541-1118 Fax: 414-541-3066 | |
Michael H Lembezeder, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 8800 W Lincoln Ave, West Allis, WI 53227 Phone: 414-541-1118 Fax: 414-541-3066 | |
Janet Marshall, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 8901 W Lincoln Ave, West Allis, WI 53227 Phone: 414-328-6640 | |
Michelle Snowden-felerski, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 8901 W Lincoln Ave, West Allis, WI 53227 Phone: 414-389-5768 |